Nicholas Marston, Brigham and Women’s Hospital, Boston, USA, reports the current status of preclinical and clinical studies with the liver-specific ANGPTL4 siRNA, Lipisense, and the ANGPTL4 monoclonal antibody, MAR001.
Please login or create a FREE account to view this content
Educational Supporters of the 10th Closed Scientific Expert Meeting of the Editorial Board
Principal supporters:
Guest supporters:
